ESMO 2025: OncoDaily LIVE Coverage

asdfs

OncoDaily Party Berlin 2025

ESMO 2025

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 influential women in oncology

DESTINY-Breast11 at ESMO 2025: Neoadjuvant T-DXd-THP Outperforms ddAC-THP in HER2-Positive Early Breast Cancer

DESTINY-Breast11 at ESMO 2025: Neoadjuvant T-DXd-THP Outperforms ddAC-THP in HER2-Positive Early Breast Cancer

David Fredrickson: Historic Agreement to Lower Medicine Costs and Protect US Biopharma Innovation

David Fredrickson

Winette van der Graaf: The HOLISTIC Study on Quality of Life Impact in Soft Tissue Sarcoma

Winette van der Graaf

Nina Niu Sanford: ASCO LDP Class of 2025-26

Nina Niu Sanford

COMPASSION-15 Trial at ESMO 2025: Cado Plus Chemotherapy Extends Survival in HER2-Negative Gastric Cancer

Compassion-15 Trial

Elen Baloyan: The Power Behind the Voice of Oncology

Elen Baloyan

John Chan